Citation Impact
Citing Papers
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer.
2013
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Genomic architecture of inflammatory bowel disease in five families with multiple affected individuals
2016 StandoutNobel
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study
2003
Targeting hypoxia in cancer therapy
2011 Standout
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
2008
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
Parkinson's disease
2021 Standout
Thyroid cancer
2016 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
The history of cancer epigenetics
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Founder mutations in BRCA1 and BRCA2 genes
2007
Mechanism and medical implications of mammalian autophagy
2018 Standout
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Ovarian cancer
2014 Standout
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
Literature review of SNOMED CT use
2013 Standout
Juvenile idiopathic arthritis
2007 Standout
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2010
Ageing as a risk factor for neurodegenerative disease
2019 Standout
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
2017
The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development
2005
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
Familial autoinflammatory diseases: genetics, pathogenesis and treatment
2005
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
2002
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines
2004
Metazoan MicroRNAs
2018 Standout
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
2019
Increased frequency of long androgen receptor CAG repeats in male breast cancers
2004
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention
2004
Modulation of GABAA receptor gene expression by allopregnanolone and ethanol
2004
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Male breast cancer
2006 Standout
Modifiers of risk of hereditary breast and ovarian cancer
2002
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Cancer risks among BRCA1 and BRCA2 mutation carriers
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
The PI3K Pathway in Human Disease
2017 Standout
The associations between Parkinson’s disease and cancer: the plot thickens
2015
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer
2004
Ten Genes for Inherited Breast Cancer
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Identification of an elaborate complex mediating postsynaptic inhibition
2016 Science
Detection of M editerranean fever gene mutations in E gyptian children with inflammatory bowel disease
2014
Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells
2004
Multicenter Breast Cancer Collaborative Registry
2011
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
2016
DNA Methylation and Cancer
2004
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
2013
Complementing the Genome with an “Exposome”: The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology
2005 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
2016
Drug Resistance in Cancer: An Overview
2014 Standout
Polymorphisms in DNA repair genes and associations with cancer risk.
2002
Works of Efrat Dagan being referenced
Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer
2000
Sleep disturbances in asymptomatic BRCA1/2 mutation carriers: women at high risk for breast-ovarian cancer
2010
Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease
2004
Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype
2002
Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women
2000
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews
2015
Quality of life in asymptomatic BRCA1/2 mutation carriers
2008
A Nonsense Mutation in the Human Homolog of Drosophila rogdi Causes Kohlschutter–Tonz Syndrome
2012
Impact of pregnancy and lactation on GABAA receptor and central-type and peripheral-type benzodiazepine receptors
1997
<b><i>LRRK2, GBA </i></b>and<b><i> SMPD1 </i></b>Founder Mutations and Parkinson's Disease in Ashkenazi Jews
2016
Anticipation in hereditary breast cancer
2002
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers
2001
Chemosensitivity and clinical characteristics of pancreatic malignancies in BRCA mutation carriers.
2013
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
2012
The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews
2005
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
2006